New Generic Blood Pressure Drug Is Approved to Relieve Shortages
The F.D.A. made the product review a priority, citing shortages that occurred in the wake of several recalls of drugs that were found to contain potentially cancer-causing chemicals.
Source: NYT Health - Category: Consumer Health News Authors: DENISE GRADY Tags: Drugs (Pharmaceuticals) Food and Drug Administration Recalls and Bans of Products Blood Pressure Zhejiang Huahai Pharmaceutical Co Ltd Teva Pharmaceutical Industries Ltd Solco Healthcare Shortages Hazardous and Toxic Substances Cancer Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | Food and Drug Administration (FDA) | Health | Toxicology